Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (458)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
72
2023
2456
3.920
 Why?
Neoplasms, Germ Cell and Embryonal
8
2026
75
2.670
 Why?
Testicular Neoplasms
8
2026
113
2.630
 Why?
Metformin
10
2018
319
2.020
 Why?
Lymph Node Excision
6
2026
173
1.800
 Why?
Tamoxifen
11
2023
217
1.600
 Why?
Receptors, Estrogen
17
2020
457
1.440
 Why?
Thyroid Hormones
2
2023
67
1.420
 Why?
Seminoma
3
2026
20
1.350
 Why?
Biomarkers, Tumor
17
2024
1322
1.230
 Why?
Receptor, ErbB-3
8
2016
48
1.220
 Why?
Lymphatic Metastasis
18
2024
334
1.190
 Why?
Cell Proliferation
16
2023
2499
1.180
 Why?
Genes, erbB-2
8
2013
33
1.030
 Why?
Cell Cycle
5
2023
597
1.020
 Why?
Mammary Neoplasms, Experimental
6
2017
70
0.990
 Why?
MicroRNAs
6
2024
701
0.890
 Why?
Apoptosis
21
2018
2430
0.860
 Why?
Estrogen Receptor alpha
3
2023
161
0.830
 Why?
Estrogens
2
2023
380
0.760
 Why?
Cell Line, Tumor
23
2023
3550
0.750
 Why?
ErbB Receptors
6
2010
629
0.640
 Why?
Up-Regulation
3
2020
852
0.630
 Why?
Hormone Replacement Therapy
1
2020
106
0.610
 Why?
Immunohistochemistry
26
2020
1718
0.590
 Why?
Mammary Neoplasms, Animal
3
2018
34
0.570
 Why?
Triple Negative Breast Neoplasms
3
2016
216
0.560
 Why?
Caspases
5
2009
232
0.550
 Why?
Disease-Free Survival
11
2020
769
0.550
 Why?
Tumor Suppressor Protein p53
14
2011
531
0.520
 Why?
Retroperitoneal Space
3
2026
18
0.500
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1462
0.470
 Why?
Prognosis
21
2020
4293
0.470
 Why?
Antineoplastic Agents
10
2018
2197
0.470
 Why?
Claudins
1
2016
23
0.470
 Why?
Receptor, IGF Type 1
3
2016
64
0.450
 Why?
Drug Resistance, Neoplasm
10
2023
883
0.450
 Why?
Trastuzumab
8
2016
118
0.430
 Why?
Quinazolines
3
2026
266
0.420
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1958
0.410
 Why?
Transcriptome
1
2020
1046
0.410
 Why?
Carcinoma, Ductal, Breast
5
2002
88
0.410
 Why?
Carcinogenesis
1
2016
229
0.410
 Why?
Signal Transduction
16
2023
5233
0.400
 Why?
Postoperative Complications
1
2026
2920
0.390
 Why?
Estradiol
2
2009
533
0.380
 Why?
Genistein
2
2010
13
0.380
 Why?
Humans
95
2026
144957
0.380
 Why?
Receptors, Steroid
2
2012
45
0.380
 Why?
Hypoglycemic Agents
3
2017
1389
0.370
 Why?
Female
69
2026
78376
0.360
 Why?
Doxorubicin
10
2011
397
0.350
 Why?
Antineoplastic Agents, Hormonal
5
2020
194
0.340
 Why?
Antimetabolites, Antineoplastic
1
2012
105
0.340
 Why?
Sweden
3
2026
111
0.320
 Why?
Receptors, Progesterone
6
2020
356
0.320
 Why?
Teratoma
2
2022
120
0.320
 Why?
STAT3 Transcription Factor
1
2012
207
0.310
 Why?
Neoplasm Invasiveness
7
2016
509
0.310
 Why?
Genes, p53
5
2000
67
0.310
 Why?
Neoplasm Staging
9
2024
1465
0.310
 Why?
Mice
18
2023
18365
0.300
 Why?
Neoplasm Proteins
5
2016
444
0.290
 Why?
Glucose
1
2013
1049
0.270
 Why?
Middle Aged
33
2026
35928
0.270
 Why?
Glycoproteins
2
2005
355
0.270
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
460
0.260
 Why?
Mammary Tumor Virus, Mouse
2
2004
45
0.260
 Why?
Mice, Transgenic
8
2018
2185
0.250
 Why?
MCF-7 Cells
4
2020
135
0.250
 Why?
Carcinoma
4
1995
228
0.240
 Why?
Ejaculation
1
2026
12
0.240
 Why?
Animals
23
2023
38109
0.240
 Why?
Neoplasm, Residual
2
2024
139
0.240
 Why?
Antibodies, Monoclonal
7
2013
1524
0.230
 Why?
Bromodeoxyuridine
2
1999
79
0.230
 Why?
Thiophenes
1
2026
128
0.230
 Why?
Multivariate Analysis
8
2005
1540
0.220
 Why?
Predictive Value of Tests
6
2024
2118
0.220
 Why?
Polymerase Chain Reaction
6
2021
1054
0.220
 Why?
Protein Kinase Inhibitors
3
2016
970
0.220
 Why?
Intraoperative Complications
1
2026
156
0.220
 Why?
Enzyme Activation
4
2009
768
0.210
 Why?
Tyrosine
2
2007
222
0.210
 Why?
Radiation Tolerance
1
2005
103
0.210
 Why?
Xenograft Model Antitumor Assays
3
2020
930
0.210
 Why?
Phosphorylation
5
2011
1733
0.200
 Why?
Cocarcinogenesis
1
2003
13
0.200
 Why?
Isoflavones
1
2003
26
0.200
 Why?
Cell Survival
5
2018
1098
0.200
 Why?
Survival Analysis
8
2005
1385
0.200
 Why?
Adult
22
2026
40506
0.190
 Why?
Paclitaxel
4
2015
256
0.190
 Why?
Chromosomes
1
2003
108
0.190
 Why?
Fluorouracil
6
2026
235
0.180
 Why?
Ki-67 Antigen
4
2014
117
0.180
 Why?
Cyclins
2
2000
84
0.180
 Why?
Chromosomes, Human, Pair 8
1
2002
38
0.180
 Why?
Gelsolin
1
2001
10
0.180
 Why?
Chromosome Aberrations
1
2002
163
0.170
 Why?
Orchiectomy
1
2021
74
0.170
 Why?
Cyclophosphamide
7
2011
266
0.170
 Why?
Breast
4
2018
159
0.170
 Why?
Proto-Oncogene Proteins c-ets
2
2020
56
0.170
 Why?
Retroperitoneal Neoplasms
1
2021
28
0.170
 Why?
Diet
3
2018
1275
0.160
 Why?
Caspase 3
4
2006
238
0.160
 Why?
Rats
7
2022
5614
0.160
 Why?
DNA-Binding Proteins
3
2020
1500
0.160
 Why?
Etoposide
1
2001
167
0.160
 Why?
Cell Division
6
2005
766
0.160
 Why?
Obesity
4
2022
3082
0.160
 Why?
Neoplastic Stem Cells
2
2014
412
0.160
 Why?
Mice, SCID
1
2020
369
0.150
 Why?
Phosphatidylinositol 3-Kinases
3
2011
381
0.150
 Why?
Transcription Factors
3
2020
1742
0.150
 Why?
Proto-Oncogene Proteins
5
2008
623
0.150
 Why?
Drug Screening Assays, Antitumor
3
2016
191
0.150
 Why?
TOR Serine-Threonine Kinases
3
2012
451
0.150
 Why?
Treatment Outcome
6
2026
11695
0.150
 Why?
Prospective Studies
4
2024
7997
0.150
 Why?
Mitotic Index
1
1999
25
0.150
 Why?
Carcinoma, Papillary
1
1999
79
0.150
 Why?
Mice, Inbred NOD
1
2020
610
0.140
 Why?
Receptors, Androgen
2
2017
153
0.140
 Why?
Antigens, Neoplasm
2
2009
272
0.140
 Why?
Chemotherapy, Adjuvant
5
2015
421
0.140
 Why?
Aromatase
1
2018
32
0.140
 Why?
Ovarian Neoplasms
4
1995
586
0.140
 Why?
Tumor Cells, Cultured
6
2009
919
0.140
 Why?
Drug Synergism
3
2018
357
0.140
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
58
0.140
 Why?
Kaplan-Meier Estimate
1
2020
966
0.140
 Why?
HSP90 Heat-Shock Proteins
1
2018
47
0.140
 Why?
Colorectal Neoplasms
1
2026
848
0.130
 Why?
Phenylthiohydantoin
2
2017
44
0.130
 Why?
Down-Regulation
3
2010
627
0.130
 Why?
Autism Spectrum Disorder
1
2023
412
0.130
 Why?
In Situ Hybridization, Fluorescence
4
2008
323
0.130
 Why?
Ovariectomy
4
2022
162
0.130
 Why?
Tumor Burden
4
2022
322
0.130
 Why?
Poly(ADP-ribose) Polymerases
2
2009
86
0.130
 Why?
Organic Cation Transport Proteins
1
2017
25
0.130
 Why?
Postmenopause
5
2022
391
0.120
 Why?
Triazoles
1
2018
184
0.120
 Why?
Antibodies, Monoclonal, Humanized
5
2013
988
0.120
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
230
0.120
 Why?
Smad Proteins
1
2016
43
0.120
 Why?
Cathepsin D
2
2002
19
0.120
 Why?
Gene Knock-In Techniques
1
2016
61
0.120
 Why?
Calcitriol
1
2016
58
0.120
 Why?
Ovary
1
2017
228
0.110
 Why?
Antibiotics, Antineoplastic
3
2009
139
0.110
 Why?
Proteins
2
1992
1022
0.110
 Why?
Male
9
2026
72406
0.110
 Why?
Gene Amplification
2
2009
121
0.110
 Why?
Protein Tyrosine Phosphatases
1
2016
168
0.110
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Immunoradiometric Assay
1
1994
1
0.110
 Why?
Immunoprecipitation
2
2011
151
0.100
 Why?
Androgen Receptor Antagonists
1
2014
35
0.100
 Why?
Young Adult
4
2024
14126
0.100
 Why?
Mental Disorders
1
2023
1172
0.100
 Why?
Postpartum Period
2
2014
365
0.100
 Why?
Disease Progression
6
2018
2852
0.100
 Why?
Insulin-Like Growth Factor I
1
2016
319
0.100
 Why?
Mice, Knockout
1
2020
3125
0.100
 Why?
Receptor, ErbB-4
2
2010
18
0.100
 Why?
Androgen Antagonists
1
2014
92
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
66
0.100
 Why?
Retrospective Studies
5
2026
17101
0.100
 Why?
Transforming Growth Factor beta
1
2016
479
0.100
 Why?
Aged
15
2026
25947
0.090
 Why?
Blotting, Western
3
2011
1187
0.090
 Why?
Adenocarcinoma
3
2012
931
0.090
 Why?
Vitamin D
1
2016
400
0.090
 Why?
Overnutrition
1
2012
30
0.090
 Why?
Nucleic Acid Hybridization
2
2003
187
0.090
 Why?
DNA, Neoplasm
6
2005
164
0.090
 Why?
Aminosalicylic Acids
1
2012
9
0.090
 Why?
Benzenesulfonates
1
2012
21
0.090
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
61
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
241
0.090
 Why?
Chromones
1
2011
42
0.090
 Why?
Gene Expression Profiling
2
2016
1786
0.090
 Why?
Genital Diseases, Female
1
1991
31
0.090
 Why?
RNA, Messenger
4
2016
2832
0.090
 Why?
Disease Models, Animal
4
2017
4569
0.090
 Why?
Dasatinib
1
2011
57
0.080
 Why?
Fluoxymesterone
1
1991
2
0.080
 Why?
Apoptosis Regulatory Proteins
1
2012
187
0.080
 Why?
Proportional Hazards Models
4
2005
1325
0.080
 Why?
Thiazoles
1
2011
136
0.080
 Why?
Mitosis
3
2001
200
0.080
 Why?
S Phase
2
2010
80
0.080
 Why?
Reagent Kits, Diagnostic
1
1991
34
0.080
 Why?
Morpholines
1
2011
129
0.080
 Why?
Cohort Studies
2
2020
5965
0.080
 Why?
Weight Gain
3
2022
559
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
55
0.080
 Why?
Proto-Oncogenes
1
1989
29
0.080
 Why?
Genital Neoplasms, Female
1
1991
99
0.080
 Why?
Neoplasm Metastasis
5
2005
695
0.080
 Why?
Radioisotopes
1
1989
37
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2032
0.080
 Why?
Flow Cytometry
3
2007
1173
0.080
 Why?
Anthracyclines
1
2009
47
0.070
 Why?
DNA Topoisomerases, Type II
1
2009
47
0.070
 Why?
Follow-Up Studies
5
2020
5417
0.070
 Why?
Aged, 80 and over
6
2002
8279
0.070
 Why?
Gene Deletion
2
2002
389
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
191
0.070
 Why?
MAP Kinase Signaling System
1
2010
311
0.070
 Why?
RNA, Small Interfering
2
2007
635
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
983
0.070
 Why?
Pyrimidines
1
2011
533
0.070
 Why?
Epithelial Cells
1
2014
1126
0.070
 Why?
Mice, Nude
1
2009
688
0.070
 Why?
Gene Dosage
1
2008
148
0.070
 Why?
Mutation
3
1995
4099
0.060
 Why?
Protein Structure, Tertiary
1
2009
862
0.060
 Why?
Reproducibility of Results
3
2023
3415
0.060
 Why?
Immunoenzyme Techniques
3
1999
200
0.060
 Why?
Time Factors
4
2015
7183
0.060
 Why?
Energy Metabolism
1
2012
936
0.060
 Why?
Proto-Oncogene Proteins c-akt
3
2016
437
0.060
 Why?
Enzyme Precursors
1
2006
15
0.060
 Why?
Thymidylate Synthase
1
2026
13
0.060
 Why?
Cell Nucleus
4
2006
619
0.060
 Why?
Receptor, Notch1
1
2006
64
0.060
 Why?
Aging
4
2003
1966
0.060
 Why?
Multigene Family
2
2003
204
0.060
 Why?
Lamin Type B
1
2005
6
0.060
 Why?
Epigenesis, Genetic
1
2010
685
0.060
 Why?
Mitochondria
3
2008
984
0.060
 Why?
Herpes Simplex
1
2006
98
0.060
 Why?
Herpesvirus 1, Human
1
2006
84
0.060
 Why?
Survival Rate
4
2020
2092
0.060
 Why?
Cell Nucleolus
1
2005
20
0.060
 Why?
Age Factors
3
2003
3335
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
112
0.050
 Why?
Benzamides
2
2017
224
0.050
 Why?
Nitriles
2
2017
205
0.050
 Why?
Antineoplastic Agents, Phytogenic
2
2007
177
0.050
 Why?
Feedback
1
2005
181
0.050
 Why?
RNA Interference
3
2015
476
0.050
 Why?
Protein Kinases
1
2006
315
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
10
0.050
 Why?
Tumor Microenvironment
2
2018
735
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
26
0.050
 Why?
Rats, Wistar
2
2017
451
0.050
 Why?
Mice, Inbred Strains
1
2004
397
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Genes, Tumor Suppressor
1
2003
83
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Adipose Tissue
2
2018
653
0.050
 Why?
Estrogen Antagonists
1
2003
48
0.050
 Why?
Plant Preparations
1
2003
37
0.050
 Why?
Cell Line
2
2003
2882
0.050
 Why?
Actins
1
2005
425
0.050
 Why?
Anticarcinogenic Agents
1
2003
61
0.050
 Why?
Chromosome Banding
1
2002
17
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
35
0.050
 Why?
Mammary Glands, Animal
1
2003
128
0.050
 Why?
Embryoid Bodies
1
2022
8
0.050
 Why?
Transfection
3
2015
940
0.050
 Why?
Rodentia
1
2022
62
0.050
 Why?
3' Untranslated Regions
2
2014
152
0.040
 Why?
Trefoil Factor-1
2
1992
2
0.040
 Why?
alpha-Fetoproteins
1
2021
40
0.040
 Why?
Fallopian Tubes
2
1991
33
0.040
 Why?
In Situ Nick-End Labeling
1
2001
121
0.040
 Why?
Chorionic Gonadotropin
1
2021
77
0.040
 Why?
RNA, Catalytic
1
2002
189
0.040
 Why?
DNA Fragmentation
1
2001
39
0.040
 Why?
Nuclear Proteins
2
2000
749
0.040
 Why?
Inhibitory Concentration 50
1
2001
91
0.040
 Why?
Plasmids
1
2002
379
0.040
 Why?
Fibrosis
1
2023
548
0.040
 Why?
Antigens, Nuclear
1
2000
16
0.040
 Why?
RNA Stability
1
2021
119
0.040
 Why?
Breast Diseases
1
2000
22
0.040
 Why?
Enhancer Elements, Genetic
1
2000
192
0.040
 Why?
Integrin beta3
2
2013
14
0.040
 Why?
Tumor Suppressor Proteins
2
1992
321
0.040
 Why?
Telomerase
1
2001
248
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
Methylnitrosourea
1
2018
7
0.040
 Why?
DNA Glycosylases
1
1998
10
0.040
 Why?
Loss of Function Mutation
1
2018
46
0.030
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.030
 Why?
Antibodies
1
2000
403
0.030
 Why?
Trans-Activators
1
2000
405
0.030
 Why?
NF-kappa B
1
2002
662
0.030
 Why?
Codon
3
1993
94
0.030
 Why?
Half-Life
1
2018
151
0.030
 Why?
Case-Control Studies
2
2023
3608
0.030
 Why?
Stromal Cells
1
2018
125
0.030
 Why?
Hyaluronan Receptors
1
1998
102
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
168
0.030
 Why?
Gene Expression
3
2013
1490
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Cell Movement
1
2001
965
0.030
 Why?
Extracellular Matrix Proteins
1
1998
159
0.030
 Why?
Steroids
1
2017
160
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
14
0.030
 Why?
Antigens, CD
2
2014
555
0.030
 Why?
DNA Repair
1
1998
256
0.030
 Why?
Oncogenes
1
2016
119
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
25
0.030
 Why?
Chromatography, Liquid
1
2017
454
0.030
 Why?
Oncogene Proteins
1
1995
61
0.030
 Why?
Analysis of Variance
2
2014
1311
0.030
 Why?
RNA
1
2001
940
0.030
 Why?
Homeodomain Proteins
1
2018
524
0.030
 Why?
Tosyl Compounds
1
2014
16
0.030
 Why?
Mammary Glands, Human
1
2014
67
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
269
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Leukocyte Common Antigens
1
2014
88
0.030
 Why?
Mass Spectrometry
1
2017
750
0.030
 Why?
Adolescent
3
2024
22453
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
65
0.030
 Why?
Parity
1
2014
109
0.030
 Why?
Neovascularization, Pathologic
1
1995
286
0.020
 Why?
Immunoassay
1
1994
109
0.020
 Why?
Premenopause
1
2014
123
0.020
 Why?
Anilides
1
2014
84
0.020
 Why?
Transplantation, Heterologous
1
2014
194
0.020
 Why?
Neoplasm Transplantation
1
2014
252
0.020
 Why?
Tomography, X-Ray Computed
1
2024
2738
0.020
 Why?
bcl-2-Associated X Protein
2
2007
54
0.020
 Why?
Testosterone
1
2017
419
0.020
 Why?
Sirolimus
2
2006
281
0.020
 Why?
Interleukin-6
1
2017
780
0.020
 Why?
Organ Specificity
1
2013
313
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2013
47
0.020
 Why?
Immune System
1
2014
179
0.020
 Why?
Lactation
1
2014
192
0.020
 Why?
Lipogenesis
1
2012
62
0.020
 Why?
Brain Neoplasms
2
1993
1322
0.020
 Why?
Point Mutation
1
1993
243
0.020
 Why?
Molecular Targeted Therapy
1
2015
434
0.020
 Why?
Neoplasms
2
2012
2884
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1217
0.020
 Why?
Astrocytoma
1
1993
129
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Gene Knockdown Techniques
1
2013
336
0.020
 Why?
Peritoneum
1
1991
45
0.020
 Why?
Mucins
1
1991
76
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
63
0.020
 Why?
Blotting, Northern
1
2010
204
0.020
 Why?
Evaluation Studies as Topic
1
1991
166
0.020
 Why?
Hormones
1
1991
134
0.020
 Why?
Glycolysis
1
2012
340
0.020
 Why?
Cells, Cultured
2
2013
4155
0.020
 Why?
In Situ Hybridization
1
2010
319
0.020
 Why?
Soft Tissue Neoplasms
1
1991
127
0.020
 Why?
Precipitin Tests
1
1989
93
0.020
 Why?
Pilot Projects
1
2015
1890
0.020
 Why?
Pregnancy
2
2014
7191
0.020
 Why?
Radionuclide Imaging
1
1989
113
0.020
 Why?
Odds Ratio
1
1992
1077
0.020
 Why?
Glioblastoma
1
1993
353
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
758
0.020
 Why?
Risk Factors
1
2003
10792
0.020
 Why?
Protein Multimerization
1
2010
214
0.020
 Why?
Lymph Nodes
1
1991
502
0.020
 Why?
Drug Interactions
1
2009
401
0.020
 Why?
Cytochromes c
1
2007
53
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
75
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
12
0.020
 Why?
Caspase 8
1
2006
47
0.020
 Why?
Caspase 9
1
2006
55
0.020
 Why?
Amino Acid Sequence
3
1998
2157
0.020
 Why?
Cysteine Endopeptidases
1
2006
73
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
17
0.020
 Why?
Caspase 7
1
2006
22
0.020
 Why?
Isoenzymes
1
2007
299
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
32
0.020
 Why?
Vero Cells
1
2006
84
0.010
 Why?
Cytosol
1
2006
227
0.010
 Why?
Biomarkers
1
2017
4275
0.010
 Why?
Base Sequence
2
2003
2191
0.010
 Why?
Promoter Regions, Genetic
1
2010
1258
0.010
 Why?
Virus Assembly
1
2006
81
0.010
 Why?
Taxoids
1
2004
116
0.010
 Why?
Protein Binding
1
2010
2276
0.010
 Why?
DNA, Complementary
1
2003
277
0.010
 Why?
Protein Processing, Post-Translational
1
2006
477
0.010
 Why?
Melanoma, Experimental
1
2003
108
0.010
 Why?
Americas
1
2002
26
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
24
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
80
0.010
 Why?
Endothelial Growth Factors
1
2002
64
0.010
 Why?
Lymphokines
1
2002
130
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
84
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
35
0.010
 Why?
Cell Adhesion
1
2003
455
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
49
0.010
 Why?
Gene Targeting
1
2002
82
0.010
 Why?
Exons
2
1993
358
0.010
 Why?
Mice, Inbred C57BL
2
2003
5997
0.010
 Why?
Europe
1
2002
412
0.010
 Why?
Templates, Genetic
1
2001
63
0.010
 Why?
Molecular Sequence Data
2
1998
2931
0.010
 Why?
Substrate Specificity
1
2002
392
0.010
 Why?
DNA, Superhelical
1
2000
12
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
381
0.010
 Why?
Mice, Inbred BALB C
1
2003
1253
0.010
 Why?
Data Interpretation, Statistical
1
2002
372
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
20
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
117
0.010
 Why?
Macromolecular Substances
1
2000
224
0.010
 Why?
Pathology, Clinical
1
2000
29
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
557
0.010
 Why?
Gene Silencing
1
2000
205
0.010
 Why?
Multicenter Studies as Topic
1
2000
405
0.010
 Why?
Forecasting
1
2000
391
0.010
 Why?
Genetic Therapy
1
2000
313
0.010
 Why?
Receptors, Cell Surface
1
2000
377
0.010
 Why?
Nucleic Acid Conformation
1
2000
726
0.010
 Why?
Binding Sites
1
2000
1331
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
151
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
43
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
59
0.010
 Why?
Immunoblotting
1
1997
300
0.010
 Why?
Hyaluronic Acid
1
1998
208
0.010
 Why?
Heterozygote
1
1996
315
0.010
 Why?
Societies, Medical
1
2000
887
0.010
 Why?
Adenine
1
1998
339
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
26
0.010
 Why?
Protein Isoforms
1
1997
402
0.010
 Why?
Cyclin D1
1
1995
62
0.010
 Why?
Melanoma
1
2002
761
0.010
 Why?
Factor VIII
1
1995
104
0.010
 Why?
Single-Blind Method
1
1995
312
0.010
 Why?
United States
2
2004
15988
0.010
 Why?
Observer Variation
1
1995
355
0.010
 Why?
Transcription, Genetic
1
2000
1496
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1721
0.010
 Why?
Alleles
1
1996
881
0.010
 Why?
Biopsy
1
1995
1077
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
49
0.010
 Why?
Peripheral Nerves
1
1991
72
0.010
 Why?
Risk Assessment
1
2000
3676
0.000
 Why?
Polymorphism, Genetic
1
1993
612
0.000
 Why?
DNA
1
1996
1464
0.000
 Why?
Protein Conformation
1
1993
946
0.000
 Why?
Lung Neoplasms
1
2002
2642
0.000
 Why?
Cerebral Cortex
1
1991
465
0.000
 Why?
Glioma
1
1991
426
0.000
 Why?
Child
1
1993
22657
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (458) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)